Clinical Trials Logo

Clinical Trial Summary

Transesophageal echocardiography is commonly used during cardiac surgery. Complications of transesophageal echocardiography are rare (1,2%), but are often underestimated and can lead to unrecognized blood loss and site of infection.

This study wants to assess the mucosa of pharynx, upper larynx, esophagus and stomach prior to and after echo probe insertion during cardiac surgery with endoscopy.


Clinical Trial Description

Transesophageal echocardiography is commonly used during cardiac surgery. Main reasons for its use are the evaluation of cardiac function and valve morphology previous to and after cardiac surgery.

Complications of transesophageal echocardiography are rare (1,2%). Described complications may involve the gastrointestinal, cardiovascular or respiratory system.

The major complication of transesophageal echocardiography is local injury of the GI tract. Only massive bleeding and perforation were reported, minor injuries are not noticed in the early postoperative period but may play an important role, especially in patients discomfort, source of minor unrecognized blood loss and site of infection. As oropharyngeal bacteria are known to cause endocarditis and graft infection, this site of infection may be of special interest in cardiac surgery.

Study objectives:

To assess the mucosa of pharynx, upper larynx, esophagus and stomach prior to and after TEE probe insertion during cardiac surgery using flexible endoscopy.

Design:

Open, not randomized, observer blinded, pilot study. Inclusion criteria

- Planned cardiac surgery

- Age above 18 years

- Signed informed consent

- Clinical need for intraoperative use of transesophageal echocardiography Exclusion criteria

- Recent gastrointestinal pathologies (3-6 months)

- Recent operations of the upper gastrointestinal tract (3-6 months)

- Subjects not able to understand study procedures

- No signed informed consent

- Contraindications for transesophageal echocardiography

After induction of anesthesia and insertion of all needed catheters (arterial catheter, central venous catheter, bladder catheter, and pulmonary artery catheter, if indicated) an expert physician will perform the endoscopy (Olympus; Hamburg, Germany) of pharynx, esophagus, and stomach in order to exclude (respectively map) any alteration of the mucosa.

Immediately after endoscopy the transesophageal probe (6T, 6T-RS, 6Tc, 6Tc-RS Vivid GE; USA; X7-2T, S7-2omni, Philips), covered with a special condom, will be inserted. The TOE probe will remain 7-8 hours in the GI tract.

Two standard echocardiographic examinations are routinely performed during cardiac operation; the first (prior to skin incision) is assigned as baseline evaluation of cardiac morphology and function; the second (after weaning from cardiopulmonary bypass) is performed to check the result of the surgical procedure respectively to determine cardiac function for decision-making of medical treatment. A routine TEE - examination follows guidelines for standard TEE views and examination workflow and includes a minimum of 11 views up to a maximum of 28 views, depending on the type of pathology. Average time needed to perform a standard TEE examination varies from 5-15minutes.

For these reasons the number of TEE views per examination, the length of each examination, and the different probe positions (upper esophageal, mid esophageal, transgastric and deep transgastric) during examination and the length of stay of the probe in each position will be reported. As soon as the TEE probe has been removed the second endoscopy it will be performed in the same order as the baseline endoscopy.

Possible lesions of the mucosa will be classified as described by Geene et al. (Greene 1999, #9) as follows: erythema, edema, hematoma, mucosal erosion, petechiae, and perforation. In particular pharynx, upper esophagus, mid esophagus, cardia, gastric fundus, und gastric body will be examined.

The analysis of filmed examination will be performed by the endoscopist in a second time off-line, in a blind manner. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03432559
Study type Interventional
Source Medical University of Vienna
Contact
Status Completed
Phase N/A
Start date July 1, 2009
Completion date January 31, 2018

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02537353 - Trial of Hemospray Plus Epinephrine Injection Versus Endoscopic Hemoclip Phase 4
Recruiting NCT03624517 - Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices Phase 4
Suspended NCT03337256 - Direct Discharge of Patients With Upper Gastrointestinal Bleeding From the Emergency Department After Endoscopy N/A
Completed NCT04472364 - HemoPill Acute ® in Suspected Nonvariceal Upper Gastrointestinal Bleeding N/A
Completed NCT05563714 - Anticoagulation With Enhanced Gastrointestinal Safety N/A
Recruiting NCT00414713 - Transfusion Requirements in Gastrointestinal (GI) Bleeding Phase 4
Completed NCT03680950 - Efficacy Test of Real-Time Upper Gastrointestinal Monitoring System N/A
Completed NCT05085405 - Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS) Trial N/A
Recruiting NCT06077916 - Gastric CLEANsing by Intravenous AZithromycin in Urgent Endoscopy N/A
Recruiting NCT04902248 - OTSC vs. Angiographic Embolization in Patients With Refractory Non-variceal Upper Gastrointestinal Bleeding N/A
Completed NCT02446678 - Use of PillCam ESO2 in Triaging Patients Present With Upper GIB N/A
Completed NCT05631639 - Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -A Pilot Study N/A
Completed NCT02978391 - UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD N/A
Completed NCT00045799 - Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill Phase 3
Recruiting NCT03090945 - Pediatric Acute Gastrointestinal Bleeding Registry
Recruiting NCT06192355 - Single-use Versus Reusable Gastroscopes in Patients With Upper Gastrointestinal Bleeding. N/A
Recruiting NCT06297954 - Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding Phase 3
Recruiting NCT03785080 - Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients N/A
Completed NCT03667703 - Stress Ulcer Prophylaxis Versus Placebo in Critically Ill Infants With Congenital Heart Disease Phase 4
Terminated NCT02017379 - Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed. N/A